Literature DB >> 12467577

X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha.

Joerg A Kallen1, Jean-Marc Schlaeppi, Francis Bitsch, Sabine Geisse, Martin Geiser, Isabelle Delhon, Brigitte Fournier.   

Abstract

The retinoic acid-related orphan receptor alpha (RORalpha) is an orphan member of the subfamily 1 of nuclear hormone receptors. No X-ray structure of RORalpha has been described so far, and no ligand has been identified. We describe the first crystal structure of the ligand binding domain (LBD) of RORalpha, at 1.63 A resolution. This structure revealed a ligand present in the ligand binding pocket (LBP), which was identified by X-ray crystallography as cholest-5-en-3beta-ol (cholesterol). Moreover, RORalpha transcriptional activity could be modulated by changes in intracellular cholesterol level or mutation of residues involved in cholesterol binding. These findings suggest that RORalpha could play a key role in the regulation of cholesterol homeostasis and thus represents an important drug target in cholesterol-related diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467577     DOI: 10.1016/s0969-2126(02)00912-7

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  100 in total

Review 1.  Membrane catalysis of peptide-receptor binding.

Authors:  David N Langelaan; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2010-04       Impact factor: 3.626

Review 2.  Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.

Authors:  Thomas P Burris; Scott A Busby; Patrick R Griffin
Journal:  Chem Biol       Date:  2012-01-27

3.  Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.

Authors:  Yongjun Wang; Naresh Kumar; Philippe Nuhant; Michael D Cameron; Monica A Istrate; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-11-19       Impact factor: 5.100

Review 4.  Endogenous ligands for nuclear receptors: digging deeper.

Authors:  Michael Schupp; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 5.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

6.  Identification of SR3335 (ML-176): a synthetic RORα selective inverse agonist.

Authors:  Naresh Kumar; Douglas J Kojetin; Laura A Solt; K Ganesh Kumar; Philippe Nuhant; Derek R Duckett; Michael D Cameron; Andrew A Butler; William R Roush; Patrick R Griffin; Thomas P Burris
Journal:  ACS Chem Biol       Date:  2010-12-06       Impact factor: 5.100

Review 7.  Endogenously produced nonclassical vitamin D hydroxy-metabolites act as "biased" agonists on VDR and inverse agonists on RORα and RORγ.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Judith V Hobrath; Allen S W Oak; Edith K Y Tang; Elaine W Tieu; Wei Li; Robert C Tuckey; Anton M Jetten
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-28       Impact factor: 4.292

8.  High-throughput screening and chemical biology: new approaches for understanding circadian clock mechanisms.

Authors:  Tsuyoshi Hirota; Steve A Kay
Journal:  Chem Biol       Date:  2009-09-25

9.  Regulation of steroidogenic acute regulatory protein transcription in largemouth bass by orphan nuclear receptor signaling pathways.

Authors:  Jannet Kocerha; Melinda S Prucha; Kevin J Kroll; Dieter Steinhilber; Nancy Denslow
Journal:  Endocrinology       Date:  2009-11-11       Impact factor: 4.736

10.  Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.

Authors:  Yongjun Wang; Naresh Kumar; Laura A Solt; Timothy I Richardson; Leah M Helvering; Christine Crumbley; Ruben D Garcia-Ordonez; Keith R Stayrook; Xi Zhang; Scott Novick; Michael J Chalmers; Patrick R Griffin; Thomas P Burris
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.